This HTML5 document contains 178 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1097/
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38682430
rdf:type
wikibase:Item
schema:description
artikull shkencor tudományos cikk 2017年论文 научни чланак videnskabelig artikel artigo científico 2017年論文 vedecký článok article científic articol științific 2017年论文 scientific article published on July 2017 artículo científico научна статия 2017年論文 научни чланак artigo científico wissenschaftlicher Artikel scienca artikolo مقالة علمية نشرت في يوليو 2017 мақолаи илмӣ article scientifique tieteellinen artikkeli scientific article published on July 2017 επιστημονικό άρθρο 2017年論文 vědecký článek 2017年论文 articolo scientifico 2017년 논문 artigo científico 2017年の論文 บทความทางวิทยาศาสตร์ artikulong pang-agham наукова стаття, опублікована в липні 2017 2017年论文 artykuł naukowy מאמר מדעי naučni članak teaduslik artikkel 2017年论文 artikel ilmiah vitskapeleg artikkel vetenskaplig artikel বৈজ্ঞানিক নিবন্ধ bilimsel makale научная статья wetenschappelijk artikel 2017年論文 article scientific 2017年論文 artículu científicu espublizáu en 2017 2017年论文 scientific article published on July 2017 vitenskapelig artikkel bài báo khoa học სამეცნიერო სტატია 2017 nî lūn-bûn
p:P577
wds:Q38682430-AA5F7F74-28D8-495C-A368-3FAA54C70804
wdt:P577
2017-07-01T00:00:00Z
p:P407
wds:Q38682430-4A272A79-F6EE-4121-92B2-556A22B98FC9
wdt:P407
wd:Q1860
p:P2860
wds:Q38682430-3B5E10F9-336F-4121-9998-BE649BC3442C wds:Q38682430-43CDAC15-68A2-47A7-A8B4-0BBB8813D9D9 wds:Q38682430-505466B4-0081-4DDA-8721-1F6E3A3AB0C2 wds:Q38682430-555691DA-AE74-4D9F-8C04-A2759B982D0B wds:Q38682430-1B702DAC-0523-489D-B049-65649910E8FB wds:Q38682430-1E0532E6-1922-4477-BC08-3E819FE73E70 wds:Q38682430-1F29813F-304A-4FA0-B7EE-86784D498728 wds:Q38682430-26598E3F-EB21-4F56-A305-B7E0E4BCC5EF wds:Q38682430-276CE7B6-D7DF-4EA4-875B-8D242BDB217D wds:Q38682430-30E178DE-6027-434B-BCBB-522075304B04 wds:Q38682430-30F10A59-6030-462E-8B5C-FB385DBB41DF wds:Q38682430-87BAF3FC-B3FD-42D7-A343-A75CDE34F705 wds:Q38682430-887D7062-8A69-444D-AB0C-0DFF7B57D53A wds:Q38682430-889CEC5C-27EC-4427-9FF0-5F4BE50D720B wds:Q38682430-90DF91A4-8720-4FCC-95BD-5DD9128F3F61 wds:Q38682430-962C80F3-8E84-449F-8556-D22A4A0481F2 wds:Q38682430-97DC4645-2206-4CF7-A70B-55EC9D1D9526 wds:Q38682430-9E07A2D1-E954-4EF0-A4AC-B2A70E73DF10 wds:Q38682430-7D7563D2-8B0B-4C1A-8BAA-2BA68CAAD600 wds:Q38682430-84D26562-06F1-402F-9CB6-693AF1AC9B32 wds:Q38682430-E564327C-A3A8-4923-8390-59D7F8DFB21A wds:Q38682430-E7E86271-270C-4351-93D1-7325D9B876F4 wds:Q38682430-EA47F96C-EC12-44A4-A8C1-69A923FB443C wds:Q38682430-F1BDBFC6-A522-48CD-AD1F-E19D13B2B7F2 wds:Q38682430-BD29CAA5-C44B-4340-80A8-EEEA170F53C7 wds:Q38682430-C4D05296-7D34-4330-9571-23605F980432 wds:Q38682430-D71EF6FC-F44C-439D-91FD-D0AF394D2640 wds:Q38682430-04E54F85-D8C5-438E-8890-538770DEC360 wds:Q38682430-0AA97C80-9144-433E-8E68-24B4D4342DC4 wds:Q38682430-0B15A4F3-8278-4480-996F-A33767001023 wds:Q38682430-175D42CE-2E20-46EC-AF4B-B3C389E8E404 wds:Q38682430-1A2B1A62-9490-4EBE-A77A-86E712334C3B
wdt:P2860
wd:Q36560240 wd:Q35960738 wd:Q29615973 wd:Q22250892 wd:Q22241898 wd:Q36144000 wd:Q37928363 wd:Q34109242 wd:Q34109319 wd:Q37080248 wd:Q37215490 wd:Q83497336 wd:Q46774898 wd:Q74432253 wd:Q34614524 wd:Q34625337 wd:Q37259538 wd:Q46591896 wd:Q38048231 wd:Q50931076 wd:Q84963675 wd:Q36297833 wd:Q44912661 wd:Q22241925 wd:Q34964594 wd:Q36759789 wd:Q43143850 wd:Q37979401 wd:Q46847423 wd:Q29618123 wd:Q45256257 wd:Q29547282
p:P2093
wds:Q38682430-A5701294-A842-44DD-B472-4D7AC07E799A wds:Q38682430-861571EF-CF51-477C-8B1D-0999FDEA4947 wds:Q38682430-83E26479-6F7C-48A2-B2E6-5EECC6B3312A wds:Q38682430-6C84C81A-EE75-4DE6-83F1-E129AC6838AF wds:Q38682430-47A58645-8067-4B0B-BBAB-E72C5838185B wds:Q38682430-27D2BE01-9934-492B-B974-689ACEC01760 wds:Q38682430-0E6F8220-2CB8-4721-A9F4-A7A96FEED505 wds:Q38682430-08DA223F-6C0C-4498-92D3-FF05CB7ECA3D
wdt:P2093
Chi-Tai Kuo Jia-Rou Liu Lung-Sheng Wu Kuang-Tso Lee Ming-Shien Wen Shang-Hung Chang Yung-Hsin Yeh Cheng-Hung Lee
rdfs:label
Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study
skos:prefLabel
Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study
schema:name
Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study
p:P50
wds:Q38682430-70372D3F-BB07-45F4-80EF-0BF8F101FDDE
wdt:P50
wd:Q51081076
p:P1476
wds:Q38682430-3B86B701-189A-4B7F-8177-5591A9BA0572
wdt:P1476
Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study
p:P304
wds:Q38682430-CCAB3AE4-ADD9-49E0-B696-7FEAD2FB3C83
wdt:P304
e7507
p:P31
wds:Q38682430-C6967DBF-A6DA-4F42-AEA2-9EBA8DDECB58
wdt:P31
wd:Q13442814
p:P921
wds:Q38682430-E161F2A3-1D82-47EB-A184-5DE7AAB46B45 wds:Q38682430-9F72AFD5-7600-4A89-8FF4-D45CC9BE3F52
wdt:P921
wd:Q3025883 wd:Q19484
p:P698
wds:Q38682430-F315ABC0-53A3-4952-9E6B-FE7A1F47A4F3
wdtn:P698
n8:28700501
wdt:P698
28700501
p:P1433
wds:Q38682430-A1519727-D63F-4485-9D97-563EF031F256
wdt:P1433
wd:Q15716652
p:P433
wds:Q38682430-FA938E9A-5486-4220-B894-975B87BBF2A7
p:P478
wds:Q38682430-787E2726-8E1E-4409-B20C-3209C25D959B
wdt:P433
28
wdt:P478
96
p:P356
wds:Q38682430-714E1A88-49F9-4938-A739-0A7E48A34CB8
wdtn:P356
n12:MD.0000000000007507
wdt:P356
10.1097/MD.0000000000007507
p:P932
wds:Q38682430-7AAEC61F-D187-4A2E-9412-1498262DDCBE
wdt:P932
5515773